Zanocin F 200mg/200mg Tablet is a combination pharmaceutical formulation containing Ofloxacin 200mg and Flavoxate 200mg, indicated for the treatment of urinary tract infections accompanied by symptoms of urinary urgency, frequency, and dysuria. Ofloxacin, a broad-spectrum fluoroquinolone antibiotic, exerts bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and transcription. It is effective against a wide range of Gram-positive and Gram-negative pathogens commonly implicated in urinary tract infections. Flavoxate, a urinary antispasmodic agent, acts by relaxing the smooth muscles of the urinary tract, reducing bladder spasms and alleviating associated pain and discomfort. The combination of these two agents provides both antimicrobial action and symptomatic relief, improving patient compliance and therapeutic outcomes. Zanocin F is typically administered orally, with dosage tailored according to the severity of infection and patient response. Caution is advised in patients with known hypersensitivity to fluoroquinolones or anticholinergic agents, and it should be used judiciously in individuals with renal impairment. Common adverse effects may include gastrointestinal disturbances, dizziness, and mild urinary discomfort. Consultation with a healthcare professional is recommended before initiating therapy to ensure appropriate use and monitoring.